Noel C. Karalus
Hamilton, WKO, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study.
Journal: The Lancet. Respiratory medicine
Published: October 16, 2024
Complete Genome Sequence of a New Zealand Mycobacterium tuberculosis Strain Responsible for Ongoing Transmission over the Past 30 Years.
Journal: Microbiology resource announcements
Published: October 13, 2022
Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial.
Journal: The European respiratory journal
Published: August 06, 2021
Dispersal of Mycobacterium tuberculosis Driven by Historical European Trade in the South Pacific.
Journal: Frontiers in microbiology
Published: September 02, 2019
Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.
Journal: The Lancet. Respiratory medicine
Published: February 08, 2019
Evaluation of the rapid molecular diagnostic test for the New Zealand Mycobacterium tuberculosis Rangipo strain in a clinical setting.
Journal: The New Zealand medical journal
Published: July 13, 2018
Cardiac dysfunction in exacerbations of chronic obstructive pulmonary disease is often not detected by electrocardiogram and chest radiographs.
Journal: Internal medicine journal
Published: May 30, 2018
Rapid molecular diagnosis of the Mycobacterium tuberculosis Rangipo strain responsible for the largest recurring TB cluster in New Zealand.
Journal: Diagnostic microbiology and infectious disease
Published: December 06, 2016
Whole genome sequencing of Mycobacterium tuberculosis reveals slow growth and low mutation rates during latent infections in humans.
Journal: PloS one
Published: November 08, 2013
Azithromycin in non-cystic-fibrosis bronchiectasis - Authors' reply.
Journal: Lancet (London, England)
Published: January 08, 2013
Biomarkers of cardiac dysfunction and mortality from community-acquired pneumonia in adults.
Journal: PloS one
Published: December 05, 2012
Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.
Journal: Lancet (London, England)
Published: August 21, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026